Disclosures for "Levodopa-responsive Early-onset Parkinsonism in a Patient with PPP2R5D-related Neurodevelopmental Disorder"
-
Dr. Keller Sarmiento has nothing to disclose.
-
Dr. Bovenzi has nothing to disclose.
-
Dr. Quintana has nothing to disclose.
-
Ms. Kinsley has nothing to disclose.
-
Dr. Bustos has nothing to disclose.
-
Dr. Krainc has nothing to disclose.
-
The institution of Dr. Mencacci has received research support from NIH.